Dan Poneman
Analyst · Lake Street Capital Markets. Please proceed
Thank you, Dan. And thank you to everyone on the call today. I am pleased to report that after returning to profitability in 2020, Centrus Energy is continuing that trend and had a strong and profitable second quarter of 2021. We saw a total revenue of $62.4 million and posted a net profit of $11.6 million for the second three months of the year. As always, we could not have done this without the hard work and incredible talent of our employees. I’m so proud of all that we have accomplished together, particularly under the unique and ongoing challenges presented by COVID-19. As noted on previous calls, we have been making our customer deliveries without interruption and benefit from the fact that most of our revenue comes from stable long-term contracts. Our LEU business continues to perform well, and we’ve been adding new sales commitments since the beginning of the year. The overall pricing in the LEU market continues to increase each quarter in both the spot and long-term markets, showing positive momentum in the uranium enrichment market. As part of our three-year, $115 million contract with the United States Department of Energy, we are on track to begin demonstrating production of high assay low enriched uranium, or HALEU, by next year. All of the centrifuges have been assembled, construction of the support system is well underway, and in June we secured approval of our license amendment application from the U.S. Nuclear Regulatory Commission, making the American Centrifuge Plant in Piketon, Ohio, the first and only U.S. enrichment facility licensed to produce HALEU. This is a major milestone, not only for Centrus, but for the restoration of American nuclear leadership on the world stage in support of the next generation of advanced nuclear reactors. While Centrus has managed to keep our own construction work on track throughout the pandemic, as we have previously noted, the pandemic has affected some of our suppliers, which has created some challenges. The challenges related to COVID include increased delays from vendors and higher costs. We are working with the Department of Energy to minimize the impacts and to address these cost increases as we go forward. As regular listeners of our earnings calls will know, getting a domestic source of HALEU enrichment up and running is critical to the future success of advanced reactors in the United States. The Department of Energy has made a multi-billion-dollar commitment to these next generation reactors as part of the Advanced Reactor Demonstration Program or ARDP, which will support the construction of two commercial scale advanced reactors in the next seven years and is helping to advance eight other designs toward commercialization. That program cannot succeed without HALEU, since 9 of the 10 reactor designs the department selected for the program, including the two major demonstrations by X-energy and TerraPower, are expected to operate on HALEU. I should note that a number of the advanced reactor developers are reported to be making tremendous progress. In April, it was reported that X-energy signed an MOU with Energy Northwest and a local public utility district to work on citing, building and operating an Xe-100 advanced nuclear power plant in Richland, Washington. And in May, TerraPower joined with PacifiCorp and Governor Mark Gordon to announce that they are working to cite their reactor at a retiring coal plant in Wyoming. And last year, Oklo, developer of the Aurora microreactor submitted the first ever combined license application for an advanced non-light water reactor to the nuclear regulatory commission, and Oklo also requires HALEU fuel. We are thrilled to see these companies moving so quickly to bring their next generation HALEU fueled markets, reactors to market. The initial capacity of our HALEU demonstration will be modest. However, the facility in Ohio is large. It could accommodate enough centrifuges to meet any level of HALEU demand, and we have a modular expansion model so that we can match our capacity to market demand. As explained more fully in our quarterly filing, our ability to operate and to expand the facility is subject to the availability of additional funding and/or offtake agreements. While we are hopeful about that and believe HALEU has a critical role to play in America’s nuclear future, there are no guarantees. Now for more details on the quarterly financial results, I will turn the call over to Philip. Philip?